Literature DB >> 24665073

Adapted chondrogenic differentiation of human mesenchymal stem cells via controlled release of TGF-β1 from poly(ethylene oxide)-terephtalate/poly(butylene terepthalate) multiblock scaffolds.

Ana Rey-Rico1, Jagadeesh K Venkatesan, Jerome Sohier, Lorenzo Moroni, Magali Cucchiarini, Henning Madry.   

Abstract

Controlled release of TGF-β1 from scaffolds is an attractive mechanism to modulate the chondrogenesis of human bone marrow mesenchymal stem cells (hBMSCs) that repopulate articular cartilage defects. Here, we evaluated the ability of porous scaffolds composed of poly(ethylene oxide)-terephtalate and poly(butylene terepthalate) (PEOT/PBT) to release bioactive TGF-β1 for chondrogenesis of hBMSCs in a pellet culture model. Chondroinduction was compared with that promoted by direct addition of the recombinant factor to the culture medium. The data show a controlled release of TGF-β1 from scaffolds for at least 21 days in vitro, with ∼10% of TGF-β1 released during this period. The delivered TGF-β1 was bioactive, as confirmed by successful chondrogenic differentiation of hBMSCs monitored by morphological, histological, immunohistochemical, biochemical, and real-time reverse transcription polymerase chain reaction analyses. Third, semiquantitative histological evaluations revealed a similar pattern of chondrogenesis compared with the positive controls. Importantly, TGF-β1-loaded scaffolds allowed for a ∼700-fold upregulation of type-II collagen mRNA compared to when pellets were maintained in the presence of the soluble TGF-β1, reflected also in the highest score of immunoreactivity to type-II collagen, not significantly different from the positive controls. Likewise, aggrecan mRNA was ∼200-fold upregulated. Interestingly, most (>94%) of the glycosaminoglycan produced remaining associated with the pellets. Analysis of hypertrophic events showed no significant difference in the average total hypertrophy score compared with the positive controls. These results demonstrate the suitability of controlled TGF-β1 release from biocompatible scaffolds to promote hBMSC chondrogenesis at a physical distance and in the absence of soluble TGF-β1.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  TGF-β1; bioactivity; chondrogenesis; controlled release; mesenchymal stem cells; scaffold

Mesh:

Substances:

Year:  2014        PMID: 24665073     DOI: 10.1002/jbm.a.35181

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  11 in total

Review 1.  Honing Cell and Tissue Culture Conditions for Bone and Cartilage Tissue Engineering.

Authors:  Johnny Lam; Esther J Lee; Elisa C Clark; Antonios G Mikos
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 2.  Tissue-engineering strategies to repair joint tissue in osteoarthritis: nonviral gene-transfer approaches.

Authors:  Henning Madry; Magali Cucchiarini
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

3.  Effect of dose and release rate of CTGF and TGFβ3 on avascular meniscus healing.

Authors:  Solaiman Tarafder; Joseph Gulko; Daniel Kim; Kun Hee Sim; Shawn Gutman; Jian Yang; James L Cook; Chang H Lee
Journal:  J Orthop Res       Date:  2019-03-28       Impact factor: 3.494

4.  Construction of Biocompatible Hydrogel Scaffolds With a Long-Term Drug Release for Facilitating Cartilage Repair.

Authors:  Wei Zhang; Rui Chen; Xiong Xu; Liang Zhu; Yanbin Liu; XiaoJie Yu; GuoKe Tang
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

5.  Chondrogenic Differentiation Processes in Human Bone-Marrow Aspirates Seeded in Three-Dimensional-Woven Poly(ɛ-Caprolactone) Scaffolds Enhanced by Recombinant Adeno-Associated Virus-Mediated SOX9 Gene Transfer.

Authors:  Jagadeesh K Venkatesan; Franklin T Moutos; Ana Rey-Rico; Bradley T Estes; Janina Frisch; Gertrud Schmitt; Henning Madry; Farshid Guilak; Magali Cucchiarini
Journal:  Hum Gene Ther       Date:  2018-06-11       Impact factor: 5.695

6.  New trends in articular cartilage repair.

Authors:  Magali Cucchiarini; Christel Henrionnet; Didier Mainard; Astrid Pinzano; Henning Madry
Journal:  J Exp Orthop       Date:  2015-04-02

7.  Biomedical-grade, high mannuronic acid content (BioMVM) alginate enhances the proteoglycan production of primary human meniscal fibrochondrocytes in a 3-D microenvironment.

Authors:  Ana Rey-Rico; Angelique Klich; Magali Cucchiarini; Henning Madry
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

Review 8.  The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review.

Authors:  Andy Goldberg; Katrina Mitchell; Julian Soans; Louise Kim; Razi Zaidi
Journal:  J Orthop Surg Res       Date:  2017-03-09       Impact factor: 2.359

9.  Remodeling of Human Osteochondral Defects via rAAV-Mediated Co-Overexpression of TGF-β and IGF-I from Implanted Human Bone Marrow-Derived Mesenchymal Stromal Cells.

Authors:  Stephanie Morscheid; Jagadeesh Kumar Venkatesan; Ana Rey-Rico; Gertrud Schmitt; Magali Cucchiarini
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

10.  3D-printed bioactive scaffolds from nanosilicates and PEOT/PBT for bone tissue engineering.

Authors:  James K Carrow; Andrea Di Luca; Alireza Dolatshahi-Pirouz; Lorenzo Moroni; Akhilesh K Gaharwar
Journal:  Regen Biomater       Date:  2018-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.